BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elewa MA, Al-Gayyar MM, Schaalan MF, Abd El Galil KH, Ebrahim MA, El-Shishtawy MM. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. Clin Exp Metastasis 2015;32:479-93. [PMID: 25999065 DOI: 10.1007/s10585-015-9721-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ke R, Cai Q, Chen Y, Lv L, Jiang Y. Diagnosis and treatment of microvascular invasion in hepatocellular carcinoma. Eur Surg 2020;52:55-68. [DOI: 10.1007/s10353-019-0573-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Cao S, Zhu S, Yin W, Xu H, Wu J, Wang Q. Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization. Onco Targets Ther 2020;13:9407-17. [PMID: 33061427 DOI: 10.2147/OTT.S257271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wu T, Jiang X, Xu B, Wang Y. [Ponatinib inhibits growth of patient-derived xenograft of cholangiocarcinoma expressing FGFR2-CCDC6 fusion protein in nude mice]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1448-56. [PMID: 33118510 DOI: 10.12122/j.issn.1673-4254.2020.10.10] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 El-Far YM, Khodir AE, Noor AO, Almasri DM, Bagalagel AA, Diri RM, Kutbi HI, Al-Gayyar MMH. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis in vivo and in vitro. Redox Rep 2020;25:17-25. [PMID: 32172678 DOI: 10.1080/13510002.2020.1739870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Porav-Hodade D, Martha O, Balan D, Tataru S, Hutanu A, Sin A, Vartolomei MD. Fascin is secreted in male's serum: results of a pilot study. Future Sci OA 2018;4:FSO273. [PMID: 29568562 DOI: 10.4155/fsoa-2017-0098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Riba A, Deres L, Eros K, Szabo A, Magyar K, Sumegi B, Toth K, Halmosi R, Szabados E. Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure. PLoS One 2017;12:e0175195. [PMID: 28384228 DOI: 10.1371/journal.pone.0175195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
7 Abdel-hamid NM, Mahmoud TK, Abass SA, El-shishtawy MM. Expression of thioredoxin and glutaredoxin in experimental hepatocellular carcinoma—Relevance for prognostic and diagnostic evaluation. Pathophysiology 2018;25:433-8. [DOI: 10.1016/j.pathophys.2018.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Salama M, Nomir M, Fahmi M, El-gayar A, El-shishtawy M. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. Sci Pharm 2018;86:44. [DOI: 10.3390/scipharm86040044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Alyoussef A, Al-Gayyar MMH. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomed Pharmacother 2018;103:362-72. [PMID: 29669302 DOI: 10.1016/j.biopha.2018.04.060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
10 Alyoussef A. The therapeutic effects of blocking IGF-R1 on mice model of skin cancer. J Dermatolog Treat 2020;:1-9. [PMID: 31868059 DOI: 10.1080/09546634.2019.1708243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mohamed AA, Zaghloul RA, Abdelghany AM, El Gayar AM. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement. J Biochem Mol Toxicol 2022;:e22989. [PMID: 35179263 DOI: 10.1002/jbt.22989] [Reference Citation Analysis]
12 Hassan HM, El-Kannishy SMH, Alattar A, Alshaman R, Hamdan AM, Al-Gayyar MMH. Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion. Biomed Pharmacother 2021;135:111216. [PMID: 33433352 DOI: 10.1016/j.biopha.2021.111216] [Reference Citation Analysis]
13 Abass SA, Abdel-Hamid NM, Abouzed TK, El-Shishtawy MM. Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma. Biomed Pharmacother 2018;101:710-8. [PMID: 29524879 DOI: 10.1016/j.biopha.2018.02.128] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
14 Alyoussef A, Taha M. Antitumor activity of sulforaphane in mice model of skin cancer via blocking sulfatase-2. Exp Dermatol 2019;28:28-34. [PMID: 30315662 DOI: 10.1111/exd.13802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Abdel-hamid NI, El-azab MF, Moustafa YM. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model. Naunyn-Schmiedeberg's Arch Pharmacol 2017;390:379-95. [DOI: 10.1007/s00210-016-1337-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
16 Al-Gayyar MMH, Bagalagel A, Noor AO, Almasri DM, Diri R. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB. Biomed Pharmacother 2019;112:108653. [PMID: 30784932 DOI: 10.1016/j.biopha.2019.108653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Ristic B, Kopel J, Sherazi SAA, Gupta S, Sachdeva S, Bansal P, Ali A, Perisetti A, Goyal H. Emerging Role of Fascin-1 in the Pathogenesis, Diagnosis, and Treatment of the Gastrointestinal Cancers. Cancers (Basel) 2021;13:2536. [PMID: 34064154 DOI: 10.3390/cancers13112536] [Reference Citation Analysis]
18 Tătaru OS, Martha O, Crocetto F, Barone B, Voidazan S, Borda A, Sin A, Hutanu A, Loghin A, Sin I, Porav-Hodade D, Chibelean CB, Vartolomei L, Lucarelli G, Ferro M, Osan VG, Buonerba C, Vartolomei MD. Fascin-1 and its role as a serological marker in prostate cancer: a prospective case-control study. Future Sci OA 2021;7:FSO745. [PMID: 34737886 DOI: 10.2144/fsoa-2021-0051] [Reference Citation Analysis]
19 Alshehri MA, Alshehri MM, Albalawi NN, Al-Ghamdi MA, Al-Gayyar MMH. Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma. Oncol Lett 2021;21:173. [PMID: 33552290 DOI: 10.3892/ol.2021.12434] [Reference Citation Analysis]
20 Sherif IO, Al-Gayyar MMH. Oleuropein potentiates anti-tumor activity of cisplatin against HepG2 through affecting proNGF/NGF balance. Life Sci 2018;198:87-93. [PMID: 29476769 DOI: 10.1016/j.lfs.2018.02.027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
21 Abd El Salam ASG, Samra YA, El-shishtawy MM. Cinnamaldehyde Relieves Induced Hepatocellular Carcinoma in Rat Model via Targeting Wnt/β-Catenin Pathway. Sci Pharm 2022;90:22. [DOI: 10.3390/scipharm90020022] [Reference Citation Analysis]
22 Radwan RR, Ali HE. Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma. Drug Deliv Transl Res 2021;11:261-78. [PMID: 32488816 DOI: 10.1007/s13346-020-00792-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Abd Elhameed AG, Helal MG, Said E, Salem HA. Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: A novel suppressive impact on Wnt/Hedgehog/Notch1 signaling. Environ Toxicol Pharmacol 2021;86:103668. [PMID: 33945853 DOI: 10.1016/j.etap.2021.103668] [Reference Citation Analysis]
24 Alyoussef A. Antitumor activity of adiponectin in mice model of skin cancer via modulation of sulfatase-2 and MMP9 activity on HSPGs. Biologia. [DOI: 10.1007/s11756-022-01018-6] [Reference Citation Analysis]
25 Helmy SA, El-Mesery M, El-Karef A, Eissa LA, El Gayar AM. Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model. Chem Biol Interact 2018;279:84-94. [PMID: 29133031 DOI: 10.1016/j.cbi.2017.11.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
26 Delire B, Henriet P, Lemoine P, Leclercq IA, Stärkel P. Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages. Cancer Sci 2018;109:2141-52. [PMID: 29727510 DOI: 10.1111/cas.13628] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hou J, Zou Q, Wang Y, Gao Q, Yao W, Yao Q, Zhang J. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation. J Biomol Struct Dyn 2019;37:3135-49. [PMID: 30079817 DOI: 10.1080/07391102.2018.1509019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
28 Wang Y, Ding X, Wang S, Moser CD, Shaleh HM, Mohamed EA, Chaiteerakij R, Allotey LK, Chen G, Miyabe K, McNulty MS, Ndzengue A, Barr Fritcher EG, Knudson RA, Greipp PT, Clark KJ, Torbenson MS, Kipp BR, Zhou J, Barrett MT, Gustafson MP, Alberts SR, Borad MJ, Roberts LR. Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein. Cancer Lett. 2016;380:163-173. [PMID: 27216979 DOI: 10.1016/j.canlet.2016.05.017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]